Studies: E-cigarettes won't help smokers quit, but they may become addicted to vaping

September 02, 2020

E-cigarettes are now the most popular product used for smoking cessation in the United States, ahead of all U.S. Food and Drug Administration (FDA)-approved cessation aids combined, from nicotine patches and gum to prescription medications. However, two recently published analyses of a large nationally representative longitudinal study report that e-cigarettes are not effective in helping adults to quit smoking. However, more research is needed to identify whether these findings also extend to newer e-cigarette designs, which may deliver nicotine as effectively as cigarettes.

The analyses were led by University of California San Diego School of Medicine researchers using data from the Population Assessment of Tobacco and Health (PATH) Study, a longitudinal study of tobacco use and its effect on the health of people in the United States. The PATH Study, undertaken by the National Institute on Drug Abuse (NIDA) and the FDA Center for Tobacco Products under contract to Westat, enrolled a nationally representative sample of 45,971 adults and youth between September 2013 and December 2014 and re-interviewed them annually for the first four years.

The analysis, published online September 2, 2020 in the journal PLOS ONE, considered 2,770 daily smokers who reported trying to quit smoking during the first follow-up year; 23.5 percent used e-cigarettes in 2014-15 (before nicotine salt technology in e-cigarettes) to help with their quit attempt. At the second follow-up one year later, 9.6 percent of e-cigarette users had been abstinent from smoking over the previous 12 months compared to 9.5 percent who did not use an e-cigarette and 10.2 percent who used neither an e-cigarette or a pharmaceutical aid. There was no evidence that cessation rates differed between e-cigarette users and closely matched smokers who did not use e-cigarettes.

"Among this representative sample of U.S. smokers trying to quit, we found no evidence that e-cigarettes were helpful in the quit attempt," said John P. Pierce, PhD, Professor Emeritus of Cancer Prevention at UC San Diego Moores Cancer Center and the study's first author. "This lack of effectiveness was also apparent in the sub-sample who used e-cigarettes on a daily basis for this quit attempt."

The second analysis, published online on July 27, 2020 in the American Journal of Epidemiology, considered 2,535 daily and non-daily smokers from the PATH Study's wave 2 survey who reported making a quit attempt during the next follow-up year. Seventeen percent of these used e-cigarettes to help with the quit attempt in 2015-16 (also before the increase in sales of e-cigarettes with nicotine salt technology). At the subsequent wave 4 follow up survey, 13 percent reported not smoking for at least 12 months -- a somewhat higher rate than the in first analysis (PLOS One paper), attributed to the inclusion of non-daily smokers who are known to have higher quit rates.

Again, study authors said there was no evidence that cessation rates differed from closely matched smokers who did not use e-cigarettes. However, in this analysis, it was clear that participants who used e-cigarettes to quit smoking were less likely to be nicotine-free at follow-up. This was largely because many of those who did quit smoking cigarettes were still using e-cigarettes, which also contain nicotine.

"In these analyses, we carefully matched each smoker who used e-cigarettes as a cessation aid with up to two similar smokers who tried to quit without using e-cigarettes," said Karen Messer, PhD, professor of family medicine and public health, director of biostatics at UC San Diego Moores Cancer Center and senior author on both papers. "Our results suggest that these smokers would have been just as successful in quitting smoking without the use of e-cigarettes. However, without the use of e-cigarettes they would have been more successful in breaking their nicotine dependence."
-end-
Co-authors for the PLOS ONE study, include: Tarik Benmarhnia, Ruifeng Chen, Martha White, Sheila Kealey. and Dennis R. Trinidad, all of UC San Diego; David B. Abrams and Raymond S. Niaura, of New York University; Bridget K. Ambrose, Nicolette Borek, Blair Coleman, James Henrie, Jean Limpert, Carolina Ramôa, Ethel Taylor, and Lisa D. Gardner, all of the Food and Drug Administration; Carlos Blanco, Kelvin Choi, Wilson M. Compton, and Heather L. Kimmel, all of the National Institutes of Health; K. Michael Cummings, Medical University of South Carolina; Cristine D. Delnevo and Michael B. Steinberg, of Rutgers Center for Tobacco Studies; Tara Elton-Marshall, Centre for Addiction and Mental Health; Maciej L. Goniewicz, Karin A. Kasza, and Maansi Bansal-Travers, all of Roswell Park Comprehensive Cancer Center; Shannon Gravely, University of Waterloo; Geoffrey T. Fong, University of Waterloo and Ontario Institute for Cancer Research; Dorothy Hatsukami, University of Minnesota; Eva Sharma and Cassandra A. Stanton, of Westat; Marushka L. Silveira, National Institutes of Health and Kelly Government Solutions; Andrew Hyland, Roswell Park Comprehensive Cancer Center and Westat; and Samir Soneji, Gillings School of Global Public Health.

This research was funded, in part, by the National Institute on Drug Abuse, National Institutes of Health and the Food and Drug Administration's Center for Tobacco Products under contract to Westat (HHSN271201100027C). Full study:
Disclosures: Cummings has received payment as a consultant to Pfizer, Inc., for service on an external advisory panel to assess ways to improve smoking cessation delivery in health care settings. He also has served as paid expert witness in litigation filed against the tobacco industry. Goniewicz receives fees for serving on an advisory board from Johnson & Johnson and grant support from Pfizer. Compton reports long-term stock holdings in General Electric Company, 3M Company and Pfizer Incorporated, unrelated to this manuscript.

Co-authors for the American Journal of Epidemiology study include: Ruifeng Chen, Eric C. Leas, Martha M. White, Sheila Kealey, David R. Strong, Dennis R. Trinidad, and Tarik Benmarhnia, all of UC San Diego. This research was funded, in part, by the National Institutes of Health (RO1CA234539) as well as the California Tobacco-related Disease Research Program (28IR-0066).

Full study:

Disclosures: Pierce and Strong report grants from National Cancer Institute during the conduct of the study. White reports grants from National Institutes of Health during the conduct of the study.

Media Contact: Yadira Galindo, 858-249-0456,
ygalindo@health.ucsd.edu

University of California - San Diego

Related Smoking Articles from Brightsurf:

Smoking rates falling in adults, but stroke survivors' smoking rates remain steady
While the rate of Americans who smoke tobacco has fallen steadily over the last two decades, the rate of stroke survivors who smoke has not changed significantly.

What is your risk from smoking? Your network knows!
A new study from researchers at Penn's Annenberg School for Communication found that most people, smokers and non-smokers alike, were nowhere near accurate in their answers to questions about smoking's health effects.

Want to quit smoking? Partner up
Kicking the habit works best in pairs. That's the main message of a study presented today at EuroPrevent 2019, a scientific congress of the European Society of Cardiology (ESC).

Smoking and mortality in Asia
In this analysis of data from 20 studies conducted in China, Japan, South Korea, Singapore, Taiwan and India with more than 1 million participants, deaths associated with smoking continued to increase among men in Asia grouped by the years in which they were born.

Predictors of successfully quitting smoking among smokers registered at the quit smoking clinic at a public hospital in northeastern Malaysia
In the current issue of Family Medicine and Community Health, Nur Izzati Mohammad et al. consider how cigarette smoking is one of the risk factors leading to noncommunicable diseases such as cardiovascular and respiratory system diseases and cancer.

Restaurant and bar smoking bans do reduce smoking, especially among the highly educated
Smoking risk drops significantly in college graduates when they live near areas that have completely banned smoking in bars and restaurants, according to a new study in the American Journal of Epidemiology.

How the UK smoking ban increased wellbeing
Married women with children reported the largest increase in well-being following the smoking bans in the UK in 2006 and 2007 but there was no comparable increase for married men with children.

Smoking study personalizes treatment
A simple blood test is allowing Vanderbilt University Medical Center (VUMC) researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.

A biophysical smoking gun
While much about Alzheimer's disease remains a mystery, scientists do know that part of the disease's progression involves a normal protein called tau, aggregating to form ropelike inclusions within brain cells that eventually strangle the neurons.

A case where smoking helped
A mutation in the hemoglobin of a young woman in Germany was found to cause her mild anemia.

Read More: Smoking News and Smoking Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.